JP Morgan Chase
GOSS icon

JP Morgan Chase’s Gossamer Bio GOSS Stock Holding History

JP Morgan Chase’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
1,228,634
+1,135,944
+1,226% +$317K ﹤0.01% 5616
2026
Q1 		$29.7K Sell
92,690
-336,213
-78% -$528K ﹤0.01% 6404
2025
Q4 		$1.33M Buy
428,903
+234,534
+121% +$669K ﹤0.01% 4411
2025
Q3 		$511K Buy
194,369
+103,922
+115% +$229K ﹤0.01% 5019
2025
Q2 		$111K Buy
90,447
+74,825
+479% +$81.6K ﹤0.01% 5556
2025
Q1 		$17.2K Buy
15,622
+10,484
+204% +$12.1K ﹤0.01% 6195
2024
Q4 		$4.65K Buy
5,138
+4,444
+640% +$3.81K ﹤0.01% 6529
2024
Q3 		$685 Hold
694
– – ﹤0.01% 6770
2024
Q2 		$625 Sell
694
-201,204
-100% -$151K ﹤0.01% 6665
2024
Q1 		$238K Buy
+201,898
New +$222K ﹤0.01% 5252
2023
Q4 		– Sell
-43,583
Closed -$36.3K – 7658
2023
Q3 		$36.3K Buy
43,583
+39,627
+1,002% +$45.7K ﹤0.01% 5905
2023
Q2 		$4.75K Sell
3,956
-115,677
-97% -$144K ﹤0.01% 6175
2023
Q1 		$151K Sell
119,633
-797,936
-87% -$1.53M ﹤0.01% 5224
2022
Q4 		$1.99M Buy
917,569
+844,868
+1,162% +$6.96M ﹤0.01% 3559
2022
Q3 		$871K Buy
72,701
+13,697
+23% +$170K ﹤0.01% 4101
2022
Q2 		$495K Sell
59,004
-51,309
-47% -$398K ﹤0.01% 4555
2022
Q1 		$957K Buy
110,313
+64,083
+139% +$618K ﹤0.01% 4307
2021
Q4 		$523K Buy
46,230
+3,685
+9% +$43.8K ﹤0.01% 4793
2021
Q3 		$535K Buy
42,545
+1,932
+5% +$17.8K ﹤0.01% 4679
2021
Q2 		$330K Buy
40,613
+6,666
+20% +$57.8K ﹤0.01% 4957
2021
Q1 		$315K Buy
33,947
+6,465
+24% +$65.2K ﹤0.01% 4941
2020
Q4 		$266K Buy
27,482
+4,360
+19% +$42.9K ﹤0.01% 4702
2020
Q3 		$297K Buy
23,122
+6,368
+38% +$84.4K ﹤0.01% 4196
2020
Q2 		$218K Buy
16,754
+2,615
+18% +$32.9K ﹤0.01% 4218
2020
Q1 		$144K Buy
14,139
+213
+2% +$2.78K ﹤0.01% 4401
2019
Q4 		$218K Sell
13,926
-133
-0.9% -$2.68K ﹤0.01% 4629
2019
Q3 		$236K Buy
14,059
+8,064
+135% +$160K ﹤0.01% 4555
2019
Q2 		$126K Buy
5,995
+2,798
+88% +$53.5K ﹤0.01% 4842
2019
Q1 		$69K Buy
+3,197
New +$66.7K ﹤0.01% 5005

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

JP Morgan Chase's GOSS Position: Q2 2026 in Review

JP Morgan Chase increased its Gossamer Bio (GOSS) stake by 1,226% in Q2 2026, buying an estimated $317K and bringing the position to 1,228,634 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #5616.

JP Morgan Chase first reported a position in GOSS in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.99M in Q4 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • JP Morgan Chase held 1,228,634 shares of Gossamer Bio worth $201K as of Q2 2026.
  • JP Morgan Chase bought 1,135,944 Gossamer Bio shares in Q2 2026, an estimated $317K.
  • Gossamer Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5616 holding.
  • JP Morgan Chase first reported a position in Gossamer Bio in Q1 2019 and has held it in 29 quarters since.
  • JP Morgan Chase's Gossamer Bio position peaked at $1.99M in Q4 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.